<?xml version="1.0" encoding="UTF-8"?>
<p id="Par27">Clinical symptoms were assessed using the FLU-PRO Symptom Severity Assessment Tool, a participant-directed questionnaire designed to assess influenza disease severity that has been validated in both natural infection and influenza challenge studies
 <sup>
  <xref ref-type="bibr" rid="CR39">39</xref>–
  <xref ref-type="bibr" rid="CR41">41</xref>
 </sup>. In addition, a physician assessment was also performed daily for 10 days to determine the presence or absence of influenza signs/symptoms. Those assessed included arthralgia, chills, conjunctivitis, coryza, diarrhea, dry cough, dyspnea/shortness of breath, fatigue/tiredness, fever (&gt;38.0 °C), headache, myalgia, nausea, productive cough, rhinorrhea, sore throat, and sweats, as well as oxygen saturation decrease by ≥3% from baseline. The duration of symptoms, total number of symptoms experienced, and peak number of symptoms were calculated based on this physician’s assessment.
</p>
